Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Markets & Filings

Antitrust Action

DOJ or FTC challenges to mergers or market power that can block deals or force breakups.

Also known as: DOJ/FTC Enforcement, Merger Challenge

What it is
Antitrust actions are enforcement moves by the Department of Justice or Federal Trade Commission against mergers or conduct that harm competition. They can sue to block deals, demand divestitures, or seek behavioral remedies. Courts ultimately decide contested cases.
What it does
A challenge injects deal-break risk, widening merger arbitrage spreads and pressuring the target's stock toward its standalone value. Conduct cases can threaten a dominant firm's business model. Investors handicap litigation odds and remedy scenarios.
The evidence
Announced government suits to block large mergers have widened arbitrage spreads and knocked target shares below deal price.
Best for
Announced merger targets and acquirers; dominant platform names.
Pairs well with
consent-decree, 8-k, event-driven
Use cautiously with
Governments lose cases too; assuming every challenge kills a deal can leave you on the wrong side of a court win.
Cautions
Litigation timelines are long and outcomes uncertain, so arbitrage carries real gap risk.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More markets & filings

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →